Pulmonary vascular disease & thromboembolism
European Society of Cardiology Quality Indicators for the Care and Outcomes of Adults with Pulmonary Arterial Hypertension. Developed in Collaboration with the Heart Failure Association of the European Society of Cardiology
Methodological detailsEuropean Society of Cardiology (ESC) methodology, systematic review and modified Delphi, systematic review of the literature, modified Delphi method, Developed in parallel with the 2022 ESC/ERS pulmonary hypertension guidelines; involved Task Force chairs, pulmonary arterial hypertension (PAH) experts, Heart Failure Association (HFA) members and patient representatives
- ESC methodology, systematic review and modified Delphi
- Systematic review of the literature
- Modified Delphi method
- Developed in parallel with the 2022 ESC/ERS pulmonary hypertension guidelines; involved Task Force chairs, PAH experts, HFA members and patient representatives
Recommendations
As issued by the authors
23 main and one secondary quality indicators (QIs) for PAH were selected
Original publication
European Society of Cardiology Quality Indicators for the Care and Outcomes of Adults with Pulmonary Arterial Hypertension. Developed in Collaboration with the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. Published 4 April 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →